GlassScriptPhysician profile
Catherine A Logan
NPI 1740209592
$93,184.90
in general payments reported to CMS, 2019-2025
12 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $2,515 · 2021: $1,247 · 2022: $7,515 · 2023: $17K · 2024: $23K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Travel and Lodging: $4,627 · Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $50,216.36 |
| Travel and Lodging | $4,627.23 |
| Food and Beverage | $1,371.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Miach Orthopaedics, INC. | $40,890.55 | 2022-2025 | |
| Arthrex, INC. | $22,810.40 | 2019-2024 | |
| Joint Restoration Foundation, INC. | $11,962.27 | 2023-2025 | |
| Gemini Mountain Medical, LLC | $10,087.79 | 2019-2025 | |
| Vericel Corporation | $6,158.05 | 2024 | Maci |
| Smith+Nephew, INC. | $875.85 | 2019-2021 | |
| Stryker Corporation | $287.68 | 2021-2025 | Salvation, Iconix, Inspace |
| Avanos Medical | $35.31 | 2019 | |
| Zimmer Biomet Holdings, INC. | $24.00 | 2023 | Gps III Platelet Concentration System |
| Ossur Americas, INC. | $23.23 | 2024 | Miami J |
| Bioventus LLC | $15.32 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $14.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.